UnitedHealth Group, US91324P1021

UnitedHealth Group stock trades 2.63% above Friday's Xetra close

Published on 11/16/2026 at 17:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
UnitedHealth Group stock is firmer than its November 13 quote as investors track the insurer's earnings recovery. Medical-cost control remains central.

UnitedHealth Group stock in focus

  • The quote has moved higher since the November 13 market note.
  • Medical-cost trends and execution remain central to the recovery outlook.
UnitedHealth Group, US91324P1021, Illustration mit AI erstellt.

UnitedHealth Group stock traded at 375.20 euros on Lang & Schwarz at 17:00 CET on Monday, November 16, 2.63 percent above the Xetra close of Friday, November 13, at 365.60 euros. Since the November 13 market note, the quote has risen from 367.20 euros to 375.20 euros, a gain of 2.18 percent.

Recovery case still faces execution tests

Investors continue to focus on medical-cost trends, utilization and execution as UnitedHealth Group works through its recovery. The market move adds a fresh trading reference after the company raised its adjusted 2026 earnings outlook earlier in November.

The higher quote does not remove the operating questions around medical-cost management and delivery across the insurer's businesses. Those factors remain important for assessing whether the improved earnings outlook can translate into durable performance.

UnitedHealth Group stock at a glance

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • Ticker: UNH.DE
  • Trading venue: Lang & Schwarz
  • Quote: 375.20 euros at 17:00 CET on November 16, 2026
  • Change versus November 13 note: 2.18 percent higher than 367.20 euros
  • Xetra close: 365.60 euros on November 13, 2026

US equity investors can follow current market reports for broader trading conditions.

See More news and analyses on UnitedHealth Group stock.

Disclaimer...
en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70521711 | bgmi